294 related articles for article (PubMed ID: 26887552)
1. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
Zhang L; Ru J; Jie X; Che G; Jin X; Li X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
[TBL] [Abstract][Full Text] [Related]
2. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Lipinska J; Lipinska S; Kasielski M; Smolewska E
Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
Zhu T; Feng L
Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
Maraina CH; Nurdayana AK; Rusni D; Azwany Y
Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
[TBL] [Abstract][Full Text] [Related]
5. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
Qu SJ; Ye H; Jia RL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.
Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N
Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993
[TBL] [Abstract][Full Text] [Related]
7. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.
Vencovský J; Machácek S; Sedová L; Kafková J; Gatterová J; Pesáková V; Růzicková S
Ann Rheum Dis; 2003 May; 62(5):427-30. PubMed ID: 12695154
[TBL] [Abstract][Full Text] [Related]
15. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
16. A study of the roles of some immunological biomarkers in the diagnosis of rheumatoid arthritis.
Khudhair HAA
J Med Life; 2023 Aug; 16(8):1194-1200. PubMed ID: 38024817
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
18. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis.
Saraux A; Berthelot JM; Devauchelle V; Bendaoud B; Chalès G; Le Henaff C; Thorel JB; Hoang S; Jousse S; Baron D; Le Goff P; Youinou P
J Rheumatol; 2003 Dec; 30(12):2535-9. PubMed ID: 14719190
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
Keskin G; Inal A; Keskin D; Pekel A; Baysal O; Dizer U; Sengül A
Protein Pept Lett; 2008; 15(3):314-7. PubMed ID: 18336364
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis.
van Jaarsveld CH; ter Borg EJ; Jacobs JW; Schellekens GA; Gmelig-Meyling FH; van Booma-Frankfort C; de Jong BA; van Venrooij WJ; Bijlsma JW
Clin Exp Rheumatol; 1999; 17(6):689-97. PubMed ID: 10609067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]